Association between oxidative stress and telomere length in type 1 and type 2 diabetic patients

Journal of Endocrinological Investigation

Volumn 36, Issue 11, 2013, Pages 1032-1037

  Ma, D ^a   Zhu, W ^a   Hu, S ^a   Yu, X ^a   Yang, Y ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

8 OHdG; Oxidative stress; Telomere length; Type 1 diabetes; Type 2 diabetes

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LEUKOCYTE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RISK FACTOR; TELOMERE;

ADULT; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LEUKOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS; TELOMERE;

EID: 84891536097     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/9036     Document Type: Article

References (23)

1. Blackburn EH. Structure and function of telomeres. Nature 1991, 350: 569-73.
2. Zhao Y, Sfeir AJ, Zou Y, et al. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 2009, 138: 463-75.
3. Salpea KD,Humphries SE. Telomere length in atherosclerosis and diabetes. Atherosclerosis 2010, 209: 35-8.
4. Sahin E, Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 2010, 464: 520-8.
5. Finkel T, Serrano M, Blasco MA. The common biology of cancer and ageing. Nature 2007, 448: 767-74.
6. Naudi A, Jove M, Ayala V, et al. Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp Diabetes Res 2012, 2012: 696215.
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414: 813-20.
8. Napier CE, Veas LA, Kan CY, et al. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells. Biochim Biophys Acta 2010, 1803: 1142-53.
9. Salpea KD, Talmud PJ, Cooper JA, et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010, 209: 42-50.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15: 539-53.
11. Akhter J. The American Diabetes Association's Clinical Practice Recommendations and the developing world. Diabetes Care 1997, 20: 1044-5.
12. Yang Z, Huang X, Jiang H, et al. Short telomeres and prognosis of hypertension in a chinese population. Hypertension 2009, 53: 639-45.
13. Mukherjee M, Brouilette S, Stevens S, Shetty KR, Samani NJ. Association of shorter telomeres with coronary artery disease in Indian subjects. Heart 2009, 95: 669-73.
14. Adaikalakoteswari A, Balasubramanyam M, Mohan V. Telomere shortening occurs in Asian Indian Type 2 diabetic patients. Diabet Med 2005, 22: 1151-6.
15. Yan J, Yang Y, Chen C, Peng J, Ding H, Wen Wang D. Short leukocyte telomere length is associated with aortic dissection. Intern Med 2011, 50: 2871-5.
16. Olivieri F, Lorenzi M, Antonicelli R, et al. Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction. Atherosclerosis 2009, 206: 588-93.
17. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 2006, 29: 283-9.
18. Jeanclos E, Krolewski A, Skurnick J, et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes 1998, 47: 482-6.
19. Satoh M, Ishikawa Y, Takahashi Y, Itoh T, Minami Y, Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008, 198: 347-53.
20. Gonenc A, Hacisevki A, Tavil Y, Cengel A, Torun M. Oxidative stress in patients with essential hypertension: A comparison of dippers and non-dippers. Eur J Intern Med 2013, 24: 139-44.
21. Ock CY, Kim EH, Choi DJ, Lee HJ, Hahm KB, Chung MH. 8- Hydroxydeoxyguanosine: not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases. World J Gastroenterol 2012, 18: 302-8.
22. Orie NN, Zidek W, Tepel M. Increased intracellular generation of reactive oxygen species in mononuclear leukocytes from patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 2000, 108: 175-80.
23. Tentolouris N, Nzietchueng R, Cattan V, et al. White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria. Diabetes Care 2007, 30: 2909-15.